Olivia Ogilvie
CEO
Opo Bio
10/10Traction
Opo Bio specializes in cell line development for the cultivated meat industry, providing a multi-species and multi-cell type bank that supports large-scale cell culture. By supplying optimized livestock cells, Opo Bio enables producers to enhance cultivation efficiency and reduce production costs for cultivated meat products.
- Biotechnology
Updated 22 months ago
Funding
Raised to date
$940KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MatuNo round attributed
- matu.co.nz (opens in a new tab)investor website
Funding rounds are not available yet.
Founders
Product
Problem
The cultivated meat industry faces challenges in achieving scalable and cost-effective production due to the limitations of existing cell lines. Developing and optimizing cell lines for efficient large-scale culture is a complex and time-consuming process, hindering the widespread adoption of cultivated meat.
Solution
Opo Bio provides optimized cell lines specifically designed for the cultivated meat industry, enabling producers to enhance cultivation efficiency and reduce production costs. They offer a multi-species and multi-cell type bank of products for both research and commercial use, streamlining the cell line development process. By focusing on cell line optimization and cell-specific ingredient design, Opo Bio facilitates large-scale cultivated meat production.
Target Audience
Opo Bio's primary customers are cultivated meat producers seeking to improve the efficiency and reduce the costs associated with cell-based meat production.
Features
- Multi-species and multi-cell type bank of livestock cells
- Cell lines optimized for large-scale cell culture
- Products available for both research and commercial applications
- Focus on cell-specific ingredient design to enhance cell performance